Espí-López Gemma-Victoria, Ruescas-Nicolau Maria-Arantzazu, Nova-Redondo Cristina, Benítez-Martínez Josep C, Dugailly Pierre-Michel, Falla Deborah
1 Department of Physical Therapy, University of Valencia , Valencia, Spain .
2 Research Unit in Manual Locomotor Therapy, Faculty of Physiotherapy, University of Valencia , Valencia, Spain .
J Altern Complement Med. 2018 Nov;24(11):1099-1107. doi: 10.1089/acm.2018.0048. Epub 2018 Apr 30.
To determine the efficacy of suboccipital inhibitory techniques in people with migraine compared with a control treatment based on myofascial trigger point (MTrP) therapy and stretching.
A randomized, double-blind controlled pilot trial was conducted.
SETTINGS/LOCATION: University research laboratory.
Forty-six adults diagnosed with migraine with over 6 months duration.
Participants were randomized to receive either combined MTrP therapy and stretching (control group) or the control treatment plus suboccipital soft tissue inhibition (experimental group). Treatment was applied on four occasions over 8 weeks (one every 15 days), with a duration of 30 minutes per session in the experimental group and 20 min in the control group.
The impact of headache was assessed with the Headache Impact Test (HIT-6), disability by the migraine disability assessment (MIDAS), and quality of life by the Short Form Health Survey (SF-36). Both groups were assessed at baseline and 1 week immediately after the end of treatment.
The amount of change of the HIT-6 score and MIDAS scores were significantly different between groups (p < 0.05), although the SF-36 scores were not. The change in the HIT-6 score and MIDAS scores was greater in the experimental group. Both groups showed a reduction on the HIT-6 score (p < 0.001), MIDAS scores (p < 0.05), and SF-36 physical subscale, whereas the SF-36 mental subscale improved only in the experimental group (p < 0.001).
Soft tissue techniques based on MTrP therapy and stretching were helpful for improving certain aspects of migraine, such as the impact and disability caused by the headache, and the frequency and intensity of headache; however, when combined with suboccipital soft tissue inhibition, the treatment effect was larger.
与基于肌筋膜触发点(MTrP)疗法和拉伸的对照治疗相比,确定枕下抑制技术对偏头痛患者的疗效。
进行了一项随机、双盲对照试验。
大学研究实验室。
46名诊断为偏头痛且病程超过6个月的成年人。
参与者被随机分为接受MTrP联合疗法和拉伸(对照组)或对照治疗加枕下软组织抑制(实验组)。在8周内进行4次治疗(每15天一次),实验组每次治疗持续30分钟,对照组每次治疗持续20分钟。
采用头痛影响测试(HIT-6)评估头痛影响,采用偏头痛残疾评估量表(MIDAS)评估残疾程度,采用简短健康调查问卷(SF-36)评估生活质量。两组在基线时以及治疗结束后1周进行评估。
两组之间HIT-6评分和MIDAS评分的变化量有显著差异(p<0.05),尽管SF-36评分没有差异。实验组的HIT-6评分和MIDAS评分变化更大。两组的HIT-6评分(p<0.001)、MIDAS评分(p<0.05)和SF-36身体分量表均有所降低,而SF-36心理分量表仅在实验组有所改善(p<0.001)。
基于MTrP疗法和拉伸的软组织技术有助于改善偏头痛的某些方面,如头痛引起的影响和残疾,以及头痛的频率和强度;然而,与枕下软组织抑制相结合时,治疗效果更佳。